Yantai Zhenghai Bio-Tech Co Ltd (300653) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥30.47 Million ≈ $4.46 Million USD) by net assets (CN¥874.47 Million ≈ $127.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yantai Zhenghai Bio-Tech Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Yantai Zhenghai Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yantai Zhenghai Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yantai Zhenghai Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
North American Construction Group Ltd
TO:NOA
|
0.117x |
|
Doright Co.Ltd.
SHE:300950
|
-0.007x |
|
Shihlin Paper Corp
TW:1903
|
-0.002x |
|
Santana Minerals Ltd
AU:SMI
|
-0.008x |
|
Abm Investama Tbk
JK:ABMM
|
0.038x |
|
GMM Pfaudler Limited
NSE:GMMPFAUDLR
|
0.053x |
|
Zhejiang Realsun Chemical Co. Ltd.
SHE:301212
|
N/A |
|
Panoro Energy ASA
OL:PEN
|
-0.079x |
Annual Cash Flow Conversion Efficiency for Yantai Zhenghai Bio-Tech Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Yantai Zhenghai Bio-Tech Co Ltd (300653) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥888.78 Million ≈ $130.06 Million |
CN¥151.38 Million ≈ $22.15 Million |
0.170x | -10.53% |
| 2023-12-31 | CN¥948.07 Million ≈ $138.73 Million |
CN¥180.48 Million ≈ $26.41 Million |
0.190x | -12.33% |
| 2022-12-31 | CN¥865.11 Million ≈ $126.59 Million |
CN¥187.84 Million ≈ $27.49 Million |
0.217x | +2.63% |
| 2021-12-31 | CN¥785.27 Million ≈ $114.91 Million |
CN¥166.13 Million ≈ $24.31 Million |
0.212x | +15.53% |
| 2020-12-31 | CN¥646.72 Million ≈ $94.64 Million |
CN¥118.43 Million ≈ $17.33 Million |
0.183x | +4.13% |
| 2019-12-31 | CN¥588.38 Million ≈ $86.10 Million |
CN¥103.48 Million ≈ $15.14 Million |
0.176x | +20.10% |
| 2018-12-31 | CN¥529.00 Million ≈ $77.41 Million |
CN¥77.47 Million ≈ $11.34 Million |
0.146x | +8.07% |
| 2017-12-31 | CN¥483.18 Million ≈ $70.70 Million |
CN¥65.47 Million ≈ $9.58 Million |
0.136x | -37.22% |
| 2016-12-31 | CN¥228.16 Million ≈ $33.39 Million |
CN¥49.25 Million ≈ $7.21 Million |
0.216x | -15.34% |
| 2015-12-31 | CN¥179.40 Million ≈ $26.25 Million |
CN¥45.74 Million ≈ $6.69 Million |
0.255x | -47.32% |
| 2014-12-31 | CN¥63.62 Million ≈ $9.31 Million |
CN¥30.79 Million ≈ $4.51 Million |
0.484x | -58.71% |
| 2013-12-31 | CN¥29.34 Million ≈ $4.29 Million |
CN¥34.38 Million ≈ $5.03 Million |
1.172x | +133.32% |
| 2012-12-31 | CN¥-6.43 Million ≈ $-941.02K |
CN¥22.62 Million ≈ $3.31 Million |
-3.517x | -- |
About Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral repair membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etchant, dental pit and fissure sealant, light-curing composite… Read more